Showing results (31-40 of 111) with videos related to
Sort By:
Pageof 12
Retrovirology|December 19, 2018
Natural APOBEC3C variants can elicit differential HIV-1 restriction activityBrett D Anderson, Terumasa Ikeda, Seyed Arad Moghadasi, et al.Epilepsia|February 15, 2011
Amphetamine-associated seizures: clinical features and prognosisJ William L Brown, John W Dunne, Daniel M Fatovich, et al.Plos One|July 24, 2010
The interaction between AID and CIB1 is nonessential for antibody gene diversification by gene conversion or class switch recombinationZachary L Demorest, Donna A MacDuff, William L Brown, et al.Biology|May 17, 2014
A Comparison of Two Single-Stranded DNA Binding Models by Mutational Analysis of APOBEC3GKeisuke Shindo, Ming Li, Phillip J Gross, et al.Methods in Enzymology|October 10, 2024
RADD: A real-time FRET-based biochemical assay for DNA deaminase studiesChristopher A Belica, Patricia C Hernandez, Michael A Carpenter, et al.Surgical Innovation|June 24, 2017
Novel Simulation Device for Targeting Tumors in Laparoscopic Ablation: A Learning Curve StudyZeljka Jutric, Jan Grendar, William L Brown, et al.Biorxiv : the Preprint Server for Biology|April 10, 2023
APOBEC3 degradation is the primary function of HIV-1 Vif for virus replication in the myeloid cell line THP-1Terumasa Ikeda, Ryo Shimizu, Hesham Nasser, et al.Journal of Virology|August 13, 2011
Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1Judd F Hultquist, Joy A Lengyel, Eric W Refsland, et al.Nature Reviews. Neurology|November 27, 2025
Towards primary prevention of multiple sclerosisRuth Dobson, Karim L Kreft, Benjamin M Jacobs, et al.Mbio|August 9, 2023
APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1Terumasa Ikeda, Ryo Shimizu, Hesham Nasser, et al.Pageof 12